1-3 of 3
Clare Peckitt
Close
Sort by
Journal Articles

R-GEM-Lenalidomide Versus R-GEM-P As Second-Line Treatment of Diffuse Large B-Cell Lymphoma: Results from the UK NCRI Phase II Randomized Legend Trial

Andrea Kuhnl, MD, Clare Peckitt, Bijal Patel, Kirit M Ardeshna, MD, Marian P Macheta, John Radford, MD, Rod Johnson, Shankaranarayana Paneesha, Sarah Barton, Ian Chau, MD, Martin F Kaiser, MD, Ruwaida Begum, Nicola Valeri, Andrew Wotherspoon, Yong Du, Imene Zerizer, David Cunningham, MD FRCP
Journal: Blood
Blood (2017) 130 (Supplement 1): 2829.
https://doi.org/10.1182/blood.V130.Suppl_1.2829.2829
Published: 2017
Journal Articles

Improved Survival in Peripheral T-Cell Lymphoma (PTCL) Following Complete Response to First-Line Chemotherapy: 10 Year Experience at the Royal Marsden and the Christie Hospitals 2002-2012

Mary Gleeson, Kim Linton, Clare Peckitt, Adam Gibb, Eliza A Hawkes, Morgan Back, Binnaz Yasar, Kate Foley, Rebecca Lee, Joanna Dash, Hannah Johnson, Catherine O'Hara, Andrew Wotherspoon, Ayoma Attygalle, Michael Potter, Mark E Ethell, MBBChir, MA, FRCP, FRCPath, Claire Dearden, John Radford, Ian Chau, David Cunningham
Journal: Blood
Blood (2015) 126 (23): 1499.
https://doi.org/10.1182/blood.V126.23.1499.1499
Published: 2015
Journal Articles

Is Stem Cell Transplantation for Transformed Follicular Lymphoma Required in the Rituximab Era?: The Royal Marsden Experience 2003-2013

Mary Gleeson, FRCPath, Eliza A Hawkes, MD, Clare Peckitt, MSc, Andrew Wotherspoon, FRCPath, Ayoma Attygalle, PhD, Bhupinder Sharma, MD, Yong Du, MD, Mark Ethell, MD, Michael Potter, PhD, Claire Dearden, MD, Alan Horwich, MD, Ian Chau, MD, David Cunningham, FMedSci
Journal: Blood
Blood (2014) 124 (21): 1719.
https://doi.org/10.1182/blood.V124.21.1719.1719
Published: 2014